Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
MARKER COMPOSITION FOR PREDICTING PROGNOSIS OF CANCER, METHOD FOR PROGNOSIS OF CANCER AND METHOD FOR PROVIDING INFORMATION FOR DETERMINING STRATEGY OF CANCER TREATMENT
Document Type and Number:
WIPO Patent Application WO/2022/186455
Kind Code:
A1
Abstract:
The present invention relates to a marker composition for predicting the prognosis of cancer and a method for predicting the prognosis of cancer using same and, more particularly, to a marker composition for predicting the prognosis of cancer comprising an agent for measuring an expression level of mRNA or protein thereof of at least one gene selected from the group consisting of ESR1, BEST1, ACTA2, HIPK2, IGSF9, ASCC2, JUN, PPP2R5A, SMAD3, CREBBP, EP300, and DDX5, to a method for predicting the prognosis of cancer using same, and to a method for providing information for determining a strategy for treating cancer.

Inventors:
HWANG TAE HYUN (US)
PARK SUNHO (US)
CHEONG JAE HO (KR)
LEE SUNG HAK (KR)
WANG CHUNG-KANG SAM (US)
POREMBKA RYAN MATTHEW (US)
Application Number:
PCT/KR2021/018966
Publication Date:
September 09, 2022
Filing Date:
December 14, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
HWANG TAE HYUN (US)
PARK SUNHO (US)
CHEONG JAE HO (KR)
LEE SUNG HAK (KR)
WANG CHUNG KANG SAM (US)
POREMBKA RYAN MATTHEW (US)
International Classes:
C12Q1/6886; G01N33/574
Foreign References:
KR20200003917A2020-01-10
Other References:
WANG YUCHEN, LI ZHAOJUN, ZHANG ZHIHUI, CHEN XIAOGUANG: "Identification ACTA2 and KDR as key proteins for prognosis of PD‐1/PD‐L1 blockade therapy in melanoma", ANIMAL MODELS AND EXPERIMENTAL MEDICINE, vol. 4, no. 2, 1 June 2021 (2021-06-01), pages 138 - 150, XP055964020, ISSN: 2576-2095, DOI: 10.1002/ame2.12154
JUDITH E. CARSER; JENNIFER E. QUINN; CAROLINE O. MICHIE; EAMONN J. OBRIEN; W. GLENN MCCLUGGAGE; PERRY MAXWELL; ELISABETH LAM: "BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer", GYNECOLOGIC ONCOLOGY., ACADEMIC PRESS, LONDON., GB, vol. 123, no. 3, 16 August 2011 (2011-08-16), GB , pages 492 - 498, XP028110035, ISSN: 0090-8258, DOI: 10.1016/j.ygyno.2011.08.017
CARPENTER RICHARD L., GÖKMEN-POLAR YESIM: "HSF1 as a Cancer Biomarker and Therapeutic Target", CURRENT CANCER DRUG TARGETS, BENTHAM SCIENCE PUBLISHERS, HILVERSUM, NL, vol. 19, no. 7, 2 August 2019 (2019-08-02), NL , pages 515 - 524, XP055964021, ISSN: 1568-0096, DOI: 10.2174/1568009618666181018162117
WANG BING, YONG HONGMEI, ZHU HUIJUN, NI DAGUANG, TANG SIJIE, ZHANG SHU, WANG WEI, ZHOU YAN, ZHAO WEI, DING GUIPENG, ZHU JIN, LI XI: "Abnormal amphiregulin expression correlates with gastric cancer prognosis", ONCOTARGET, vol. 7, no. 47, 22 November 2016 (2016-11-22), pages 76684 - 76692, XP055964022, DOI: 10.18632/oncotarget.12436
Attorney, Agent or Firm:
C&S PATENT AND LAW OFFICE (KR)
Download PDF: